Lipocine Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.15

-0.09 (-4.02%)

As of Sep 22, 4:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +802.8% upside

Low Target $13.09

Average Target $19.41

High Target $19.72

Current Price $2.15

Current
$2.15

Target
$19.41

$13.09 $19.41 avg $19.72

Scenario Analysis

Bear Case

$13.09

508.8%

Low target

Base Case

$19.41

+802.8%

Avg target

Bull Case

$19.72

+817.2%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$12.37

-82.6% from high

52-Week Low

$1.81

+18.8% from low

Target vs 52W High

$19.41

+56.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+13.7%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+5.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+21.4%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+180.3%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+188.0%